Service firm Avara buys AstraZeneca plant | Chemical & Engineering News
Volume 94 Issue 37 | p. 13 | Concentrates
Issue Date: September 19, 2016

Service firm Avara buys AstraZeneca plant

Department: Business
Keywords: outsourcing, APIs, formulation, Crestor
Crestor (rosuvastatin)
The structure of rosuvastatin.
Crestor (rosuvastatin)

One-year-old Avara Pharmaceutical Services is continuing its rapid growth with the purchase of AstraZeneca’s active pharmaceutical ingredient (API) plant in Avonmouth, England. The facility, which employs about 210 people, mainly makes the APIs in the drugs Crestor and Seroquel. Drug industry veteran Tim Tyson launched Avara in 2015 with the purchase of a Merck & Co. formulation plant in Arecibo, P.R. Earlier this year, the firm acquired a UCB API plant in Shannon, Ireland. And last month, it acquired an Astellas Pharma drug formulation and packaging plant in Norman, Okla.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment